Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pneumonia × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8 Psoriasis 5 Leukemia 5 Myelodysplastic Syndromes 3 Lymphoma, Follicular 3 Asthma 3 Vasculitis 2 Prostatic Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Inflammation 2 Granulomatosis with Polyangiitis 2 Arthritis, Juvenile 2 Wilms Tumor 1 Uveitis 1 Temporomandibular Joint Disorders 1 Stomatitis 1 Respiratory Distress Syndrome 1 Recurrence 1 Pruritus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Plaque, Amyloid 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metabolic Syndrome 1

Interventions

Methylprednisolone 2 tocilizumab 1 pirfenidone 1 ceftolozane, tazobactam drug combination 1 XAV-19 1 Ultrasonography 1 Standard of Care 1 Sodium Bicarbonate 1 Saline Solution 1 Ribavirin 1 Prednisone 1 Nebulizers and Vaporizers 1 Lidocaine 1 Immunoglobulin G 1 Gelsolin 1 Fluoridation 1 Etanercept 1 Disulfides 1 Clinical Protocols 1 Calcitriol 1 Amifostine 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡